计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
T126856-250mg |
250mg |
现货 ![]() |
| |
T126856-1g |
1g |
现货 ![]() |
| |
T126856-5g |
5g |
现货 ![]() |
| |
T126856-25g |
25g |
现货 ![]() |
| |
T126856-100g |
100g |
现货 ![]() |
|
别名 | 沙利度胺 | (±)-2-(2,6-二氧代-3-哌啶基)-1H-异吲哚-1,3 (2H)-二酮 | (±)-Thalidomide | N-(2,6-二氧-3-哌啶基)邻苯二甲酰亚胺 |
---|---|
英文别名 | Sedalis | Sedisperil | Synovir | Talismol | Thalidomide Celgene | UNII-4Z8R6ORS6L | .alpha.-N-Phthalylglutaramide | Algosediv | Neaufatin | Pangul | Pro-ban M | thalidomide | 3-Phthalimidoglutarimide | Imida-lab | Psychotablets | Distaxal | Imidene | Dist |
规格或纯度 | Moligand™, ≥98% |
英文名称 | Thalidomide |
生化机理 | 沙利度胺在 20 世纪 50 年代后期曾被普遍用于治疗,但后来发现会导致先天缺陷,因此退出了市场。最近的研究发现,沙利度胺会影响关键的生化途径,从而产生抗血管生成和免疫调节活性。研究表明,这种化合物可以:选择性抑制 TNF α(肿瘤坏死因子-α)的生物合成和碱性成纤维细胞生长因子(bFGF)诱导的血管生成;通过细胞色素 c 依赖性途径诱导人类单核细胞凋亡;抑制单核细胞(U1)系中 HIV-1 的复制。这些新发现的用途使沙利度胺成为一种极有价值的研究工具。抗增殖、抗血管生成和促进细胞凋亡。 |
运输条件 | 常规运输 |
作用类型 | 抑制剂 |
作用机制 | CRL4(CRBN)E3 泛素连接酶抑制剂 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
应用: 沙利度胺已被用于阿尔茨海默病 (AD) 小鼠模型的神经病理学研究。该研究报道,长期服用沙利度胺可引起 β-分泌酶抑制,继而减轻类淀粉样病理。此外,沙利度胺也被用于评价其致畸功能。沙利度胺可影响人胚胎干细胞和诱导多能干细胞分化过程中的内胚层分化和神经发育。 A selective inhibitor of TNF alpha biosynthesis shown to have immunomodulatory and antiangeogenic activity. |
ALogP | 0.3 |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504750891 |
---|---|
EC号 | 200-031-1 |
分子类型 | 小分子 |
IUPAC Name | 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
INCHI | InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) |
InChi Key | UEJJHQNACJXSKW-UHFFFAOYSA-N |
Canonical SMILES | C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O |
Isomeric SMILES | C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O |
WGK Germany | 3 |
RTECS | TI4375000 |
PubChem CID | 5426 |
UN Number | 2811 |
Packing Group | I |
分子量 | 258.23 |
溶解性 | Soluble in DMSO (>25 mg/ml), cold pyridine, dimethylformamide, dioxane, Acetone, Butyl Acetate, Ethanol (≥2 mg/ml), Ethyl Acetate, Methanol, water (<1 mg/mL ), and 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin (0.6 mg/mL). |
---|---|
熔点 | 276 °C |
分子量 | 258.230 g/mol |
XLogP3 | 0.300 |
氢键供体数Hydrogen Bond Donor Count | 1 |
氢键受体数Hydrogen Bond Acceptor Count | 4 |
可旋转键计数Rotatable Bond Count | 1 |
精确质量Exact Mass | 258.064 Da |
单同位素质量Monoisotopic Mass | 258.064 Da |
拓扑极表面积Topological Polar Surface Area | 83.600 Ų |
重原子数Heavy Atom Count | 19 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 449.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 1 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
象形图 | GHS08, GHS07 |
---|---|
信号词 | Danger |
危险声明 |
H302: 吞食有害 H360: 可能损害生育力或未出生的孩子 |
预防措施声明 |
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P330: 漱口 P203: 使用前,获取、阅读并遵守所有安全说明。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P318: 如果暴露或担心,请就医。 |
WGK Germany | 3 |
RTECS | TI4375000 |
Class | 6.1 |
Merck Index | 9255 |
个人防护装备 | Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges |
Purity(HPLC) | 98-100(%) |
---|---|
Appearance(T126856) | White to Off-White Powder |
Proton NMR spectrum | Conforms to Structure |
Solubility in DMSO,Clear(>10mg/ml) | Conforms |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 25-03-17 | T126856 |
![]() |
分析证书 | 25-03-17 | T126856 |
![]() |
分析证书 | 25-03-17 | T126856 |
![]() |
分析证书 | 24-07-08 | T126856 |
![]() |
分析证书 | 24-07-08 | T126856 |
![]() |
分析证书 | 24-07-08 | T126856 |
![]() |
分析证书 | 24-07-08 | T126856 |
![]() |
分析证书 | 24-07-08 | T126856 |
![]() |
分析证书 | 24-07-02 | T126856 |
![]() |
分析证书 | 23-03-16 | T126856 |
![]() |
分析证书 | 22-07-11 | T126856 |
![]() |
分析证书 | 22-06-20 | T126856 |
¥479.92
1. Jingjing Chen, Peipei Li, Yixiu Han, Yuchen Li, Yingxiang Du. (2023) Highly photoluminescent nitrogen-doped carbon quantum dots as a green fluorescence probe for determination of myricetin. FOOD CHEMISTRY, 417 (135920). [PMID:36933427] [10.1016/j.foodchem.2023.135920] |
2. Zhe Zhou, Jing Long, Yuan Wang, YaYun Li, Xu Zhang, Ling Tang, Qi Chang, Zhuo Chen, GaoYun Hu, Shuo Hu, QianBin Li, Cong Peng, Xiang Chen. (2020) Targeted degradation of CD147 proteins in melanoma. BIOORGANIC CHEMISTRY, 105 (104453). [PMID:33197849] [10.1016/j.bioorg.2020.104453] |
1. Xin W, Xiaohua N, Peilin C, Xin C, Yaqiong S, Qihan W. (2008) Primary function analysis of human mental retardation related gene CRBN.. Mol Biol Rep, 35 (2): (251-6). [PMID:17380424] [10.1021/op500134e] |
2. Jo S, Lee KH, Song S, Jung YK, Park CS. (2005) Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain.. J Neurochem, 94 (5): (1212-24). [PMID:16045448] [10.1021/op500134e] |
3. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H. (2010) Identification of a primary target of thalidomide teratogenicity.. Science, 327 (5971): (1345-50). [PMID:20223979] [10.1021/op500134e] |
4. Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, Karasawa S, Carmel G, Jackson P, Abbasian M et al.. (2012) Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.. Leukemia, 26 (11): (2326-35). [PMID:22552008] [10.1021/op500134e] |
5. Mazzoccoli L, Cadoso SH, Amarante GW, de Souza MV, Domingues R, Machado MA, de Almeida MV, Teixeira HC. (2012) Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.. Biomed Pharmacother, 66 (5): (323-9). [PMID:22770990] [10.1021/op500134e] |
6. Eichner R, Heider M, Fernández-Sáiz V, van Bebber F, Garz AK, Lemeer S, Rudelius M, Targosz BS, Jacobs L, Knorn AM et al.. (2016) Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.. Nat Med, 22 (7): (735-43). [PMID:27294876] [10.1021/op500134e] |
7. Quayle LA et al.. (2017) Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action.. Oncotarget, 8 (51): (88670-88688). [PMID:29179466] |
8. Rosa TLSA et al.. (2022) The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.. Front Med (Lausanne), 9 (899998). [PMID:35733868] |
9. Jingjing Chen, Peipei Li, Yixiu Han, Yuchen Li, Yingxiang Du. (2023) Highly photoluminescent nitrogen-doped carbon quantum dots as a green fluorescence probe for determination of myricetin. FOOD CHEMISTRY, 417 (135920). [PMID:36933427] [10.1016/j.foodchem.2023.135920] |
10. Zhe Zhou, Jing Long, Yuan Wang, YaYun Li, Xu Zhang, Ling Tang, Qi Chang, Zhuo Chen, GaoYun Hu, Shuo Hu, QianBin Li, Cong Peng, Xiang Chen. (2020) Targeted degradation of CD147 proteins in melanoma. BIOORGANIC CHEMISTRY, 105 (104453). [PMID:33197849] [10.1016/j.bioorg.2020.104453] |